BRENNEN

Industries / Frontier science / Space manufacturing

Rules

This is the work of getting permission: the treaties, licenses and product rules that decide who may make things in orbit, who owns them and how they may come back.

7

Milestones achieved, from 1967 to 2026.

3

To watch for: announced, not yet confirmed outside.

2

Open deliverables. Nobody has shipped them.

The road

AchievedWatch forOpen

Achieved

  1. 1967

    Private work needs a state

    The Outer Space Treaty, in force since October 1967, says the activities of "non-governmental entities" in space "shall require authorization and continuing supervision by the appropriate State Party," and makes that state answer internationally for them (Article VI). Article VIII says that ownership of objects launched into space and their parts "is not affected" by their return to Earth, and that objects found outside the state that registered them must be returned to it. The Rescue Agreement, in force since December 1968, adds that the launching state pays the costs of recovering and returning them, and the Liability Convention, in force since September 1972, makes the launching state absolutely liable for damage its space objects cause on the ground or to aircraft.

    unoosa.orgunoosa.orgunoosa.org

    Credit

    UN member states, through the UN Committee on the Peaceful Uses of Outer Space

  2. 1998

    Station inventions get a country

    The Intergovernmental Agreement on the International Space Station, signed on 29 January 1998, settles where an invention made on the station is made. For intellectual property law, an activity "in or on a Space Station flight element shall be deemed to have occurred only in the territory of the Partner State of that element's registry" (Article 21), so work in a US module falls under US law. For modules registered by the European Space Agency, any European partner state may treat the activity as having happened in its territory.

    state.govesa.int

    Credit

    the governments of the ISS partnership

  3. 1998

    Reentry enters US law

    The Commercial Space Act of 1998, signed on 28 October 1998, extended the US commercial launch law to reentries. It defines a reentry vehicle as one "designed to return from Earth orbit or outer space to Earth... substantially intact." Under the law as it stands, a US citizen or company needs a license from the Federal Aviation Administration (FAA) to bring a reentry vehicle back anywhere in the world.

    govinfo.govfederalregister.gov

    Credit

    US Congress

  4. 2019

    Station opens to products

    On 7 June 2019 NASA issued a directive allowing commercial manufacturing, production and marketing on the ISS, including products for sale on Earth. NASA said this widened commercial activity beyond the mandate of the ISS National Lab, which is limited to research and development. NASA set aside 5% of its yearly share of crew time and cargo, 90 hours of crew time and 175 kg of cargo, with a limit per company, and allowed private astronaut missions of up to 30 days.

    nasa.gov

    Credit

    NASA

  5. 2024

    A capsule waits for permission

    Part 450, the FAA's single set of rules for launch and reentry licenses, was published on 10 December 2020, and the older rule sets were removed on 10 March 2026. Varda Space Industries was the first company to seek a reentry license under it. Its W-1 spacecraft launched on 12 June 2023 without a reentry license; its chief executive, William Bruey, said "there was no law or regulation that said you can't launch without your reentry license." The FAA rejected the application in September 2023; Varda said it had come close to the license and to the Air Force's approval to land at the Utah Test and Training Range, and called the delay "a coordination problem amongst three different groups that had not worked through this operation before." The capsule waited in orbit until the license came on 14 February 2024. On 17 April 2024 the FAA said it will generally not authorize the launch of a reentry vehicle that does not yet have its reentry authorization.

    LessonPermission to come home has to be in hand before launch, because a finished product cannot be brought down without it.

    spacenews.comfederalregister.govfederalregister.govpayloadspace.comaerospaceamerica.aiaa.org

    Credit

    FAA; Varda Space Industries

  6. 2024

    Australia's first return permit

    For W-1, Varda had ruled out landing outside the US because of the "time, uncertainty, and complexity" of agreements with a foreign government, by SpaceNews's account of the FAA's environmental assessment. In October 2024 the Australian Space Agency gave its first return authorization, for three Varda capsules to land at the Koonibba Test Range, a 41,000 km² site in South Australia run by the company Southern Launch. The agency's head, Enrico Palermo, credited the Technology Safeguards Agreement with the US, a treaty that Space Connect describes as letting more US rockets launch from or land in Australia. When W-2 came down there on 28 February 2025, Southern Launch said it was the first time a commercial spacecraft reentry had been granted under Australian law.

    spaceconnectonline.com.ausouthernlaunch.spacespacenews.com

    Credit

    Australian Space Agency; Southern Launch; Varda Space Industries

  7. 2026

    A route for space-made medicines

    On 5 March 2026 the UK Space Agency, the Medicines and Healthcare products Regulatory Agency (MHRA), the Regulatory Innovation Office and the Civil Aviation Authority (CAA) set out a package for drugs made in orbit: guidance, case studies, a regulatory sandbox (a supervised trial under tailored rules) and a separate Re-entry Regulatory Sandbox for returning platforms. The MHRA calls it the first dedicated regulatory pathway for space-manufactured medicines. The CAA said in-space manufacturing "can be licensed under the UK's current rules", and it had already licensed Space Forge's ForgeStar-1, which the agencies call the UK's first in-orbit manufacturing platform, launched in June 2025.

    gov.ukgov.ukmedregs.blog.gov.uk

    Credit

    UK Space Agency, MHRA, Regulatory Innovation Office and CAA

Watch for

  1. One EU rulebook for space

    The European Commission proposed the EU Space Act on 25 June 2025: one set of rules across the EU for authorizing and supervising space activities, with safety coordination and limits on casualty risk during launch and re-entry, and registration for operators outside the EU that serve EU customers. On 29 October 2026 the Council of the EU was still working from a presidency compromise text, with every member state holding a scrutiny reservation, a formal hold while national governments review it.

    Achieved whenthe European Parliament and the Council adopt the regulation and it is published in the Official Journal of the EU.

    eur-lex.europa.eudata.consilium.europa.euspace.commerce.gov

    Claimed by

    European Commission, June 2025

  2. A license for new activities

    Executive Order 14335 of 13 August 2025 told the US Secretary of Commerce to propose, within 150 days, a process for individual mission authorizations for activities covered by Article VI of the Outer Space Treaty but "not clearly or straightforwardly governed by existing regulatory frameworks", with a definitive timeline for granting or denying them. On 20 August 2026 the Office of Space Commerce invited operators to a pilot of its proposed Space Commerce Certification, and said a certificate granted in the pilot will have "no direct legal effect" and that operators must still meet FAA and Federal Communications Commission (FCC) rules.

    Achieved whena certificate is issued and the FAA or FCC relies on it in a published license decision, or a final rule or law makes the process binding.

    federalregister.govfederalregister.gov

    Claimed by

    the White House, August 2025; Office of Space Commerce, August 2026

  3. Standards for pharma payloads

    On 14 September 2026 the executive committee of ASTM International's committee on commercial spaceflight, F47, voted to form a subcommittee, F47.06, to write voluntary standards for space biotech, pharmaceutical and advanced manufacturing payloads, starting with chain-of-custody records, environmental conditions and containment. The Office of Space Commerce, which joined, announced it on 13 October 2026; NewSpace Economy lists founding participants from NIST, the Biomedical Advanced Research and Development Authority, the Food and Drug Administration (FDA) and two companies, and reports no deadline for a first standard.

    Achieved whenF47.06 publishes a standard and a flight operator or regulator cites it in a mission plan or a filing.

    space.commerce.govnewspaceeconomy.ca

    Claimed by

    ASTM and the Office of Space Commerce, October 2026

Open

  1. 01

    A clock for return permits

    A public table of every license or authorization given to bring a commercial capsule back to Earth since 2021, in the US, Australia and anywhere else. Each row gives the operator, the mission, the authority, and the dates of application (where public), approval, launch and landing, with the days a finished capsule waited in orbit for permission.

    The brief
    Credit · unclaimed
  2. 02

    Space-made medicine gap table

    For each published batch of a drug substance crystallized in orbit, a table of the quality evidence a medicines regulator expects for a batch: identity, crystal form, particle size, purity and impurities, stability, and batch and chain-of-custody records through launch and landing. Each row says whether the published report gives that evidence, cites the guideline clause the requirement comes from, and gives the page that answers it, or "not reported". It is a public research table, not regulatory advice for any product.

    The brief
    Credit · unclaimed

Open 01 · the brief

A clock for return permits

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

A public table of every license or authorization given to bring a commercial capsule back to Earth since 2021, in the US, Australia and anywhere else. Each row gives the operator, the mission, the authority, and the dates of application (where public), approval, launch and landing, with the days a finished capsule waited in orbit for permission.

Why it is still open

The FAA has 180 days to decide once it accepts an application, but the talks before an application have no set length, Aerospace America reported in January 2025. In the same report Varda's first capsule waited in orbit from a planned September 2023 return until its license came on 14 February 2024, while Inversion, a California reentry company licensed in October 2024, said it began the process about 18 months before. Reporting on how long these approvals take rests on single cases like these. A web search found no public table of reentry approvals case by case.

aerospaceamerica.aiaa.org

Built with what exists

The Federal Register API for FAA notices and environmental assessments; the license documents the FAA publishes; the Australian Space Agency's register of decisions about space activities; Jonathan McDowell's public launch and reentry lists at planet4589.org; an AI model to pull dates out of PDFs, with a person checking each date.

  1. First step

    List Varda's W-series missions and find the authorization date for each in FAA and Australian Space Agency records.

  2. Done looks like

    Every commercial capsule return from 2021 to 2026 listed, each date linked to a public record and gaps marked as unknown. A second person checks every date. The table reports, for each country, the median days from application to approval and from launch to approval.

Open 02 · the brief

Space-made medicine gap table

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

For each published batch of a drug substance crystallized in orbit, a table of the quality evidence a medicines regulator expects for a batch: identity, crystal form, particle size, purity and impurities, stability, and batch and chain-of-custody records through launch and landing. Each row says whether the published report gives that evidence, cites the guideline clause the requirement comes from, and gives the page that answers it, or "not reported". It is a public research table, not regulatory advice for any product.

Why it is still open

When the UK set out its pathway on 5 March 2026, its regulators said they were still preparing the principles-based case studies that would show the route a company follows. In June 2026 the MHRA said a regulatory roadmap mapping each stage of in-orbit manufacturing against UK rules would follow in autumn 2026. In the US, the standards subcommittee for space pharmaceutical payloads, ASTM F47.06, was only formed in September 2026. A web search found no public table that checks a flown batch against what a regulator asks before a batch is released.

gov.ukmedregs.blog.gov.ukspace.commerce.gov

Built with what exists

ICH Q6A, the international guideline on test specifications for new drug substances; UK and EU good manufacturing practice (GMP) guidance, the rules for making and recording medicine batches; the published reports of flown crystallization runs (see this file's Products domain); an AI model to read batch records and flag missing evidence (AI reviewers of drug-making records are covered in the Note "Seven more flagged").

  1. First step

    List the tests ICH Q6A sets for a new drug substance and mark which of them the published results of one flown crystallization run report.

  2. Done looks like

    A gap table for at least two flown batches, every row citing a guideline clause and a page or "not reported". A pharmaceutical quality professional who did not build it reviews the table and agrees with at least 90% of the rows, and the table and the review are published.